Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Abstract 2358: NR0B2 re-educates myeloid cells within the tumor microenvironment: Potential novel strategy for breast cancer immunotherapy

Hashni Epa Vidana Gamage, Sayyed Hamed Shahoei, Tiffany Nguyen, Rachel Farmer, Samuel Albright, Erin Weisser, Rafael O. Bautista, Claire P. Schane, Yu Wang, Adam Nelczyk, Liqian Ma, Srishti Tiwari, Anasuya Das Gupta, Shruti Bendre, Lionel Apetoh, Paul J. Hergenrother, Erik R. Nelson

Cancer Res (2023) 83 (7_Supplement): 2358.

https://doi.org/10.1158/1538-7445.AM2023-2358

Published: 04 April 2023

View article titled, Abstract 2358: NR0B2 re-educates myeloid cells within the tumor microenvironment: Potential novel strategy for breast cancer immunotherapy

Journal Articles

Abstract P6-05-01: The small heterodimer partner in macrophages reduces expansion of regulatory T cells and enhances immune checkpoint inhibition in breast cancer

Erik R. Nelson, Sayyed Hamed Shahoei, Adam T Nelson, Madeline A Henn, Ashley E Mathews, Joy J Chen, Varsha Vembar, Liqian Ma, Lionel Apetoh

Cancer Res (2020) 80 (4_Supplement): P6-05-01.

https://doi.org/10.1158/1538-7445.SABCS19-P6-05-01

Published: 15 February 2020

View article titled, Abstract P6-05-01: The small heterodimer partner in macrophages reduces expansion of regulatory T cells and enhances immune checkpoint inhibition in breast cancer

Journal Articles

Cleaved Caspase-3 Transcriptionally Regulates Angiogenesis-Promoting Chemotherapy Resistance

Antoine Bernard, Sandy Chevrier, Françoise Beltjens, Magalie Dosset, Etienne Viltard, Anaïs Lagrange, Valentin Derangère, Alexandra Oudot, François Ghiringhelli, Bertrand Collin, Lionel Apetoh, Olivier Feron, Suzie Chen, Laurent Arnould, Frédérique Végran, Romain Boidot

Cancer Res (2019) 79 (23): 5958–5970.

https://doi.org/10.1158/0008-5472.CAN-19-0840

Published: 02 December 2019

View article titled, Cleaved Caspase-3 Transcriptionally Regulates Angiogenesis-Promoting Chemotherapy Resistance

Includes: Supplementary data

Journal Articles

Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen

Emeric Limagne, Romain Euvrard, Marion Thibaudin, Cédric Rébé, Valentin Derangère, Angélique Chevriaux, Romain Boidot, Frédérique Végran, Nathalie Bonnefoy, Julie Vincent, Leila Bengrine-Lefevre, Sylvain Ladoire, Dominique Delmas, Lionel Apetoh, François Ghiringhelli

Cancer Res (2016) 76 (18): 5241–5252.

https://doi.org/10.1158/0008-5472.CAN-15-3164

Published: 15 September 2016

View article titled, Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen

Includes: Supplementary data

Journal Articles

Th9 Cells: A Novel CD4 T-cell Subset in the Immune War against Cancer

Frédérique Végran, Lionel Apetoh, François Ghiringhelli

Cancer Res (2015) 75 (3): 475–479.

https://doi.org/10.1158/0008-5472.CAN-14-2748

Published: 01 February 2015

View article titled, Th9 Cells: A Novel CD4 T-cell Subset in the Immune War against Cancer

Journal Articles

SOCS3 Transactivation by PPARγ Prevents IL-17–Driven Cancer Growth

Hélène Berger, Frédérique Végran, Madijd Chikh, Federica Gilardi, Sylvain Ladoire, Hélène Bugaut, Grégoire Mignot, Fanny Chalmin, Mélanie Bruchard, Valentin Derangère, Angélique Chevriaux, Cédric Rébé, Bernhard Ryffel, Caroline Pot, Aziz Hichami, Béatrice Desvergne, François Ghiringhelli, Lionel Apetoh

Cancer Res (2013) 73 (12): 3578–3590.

https://doi.org/10.1158/0008-5472.CAN-12-4018

Published: 13 June 2013

View article titled, SOCS3 Transactivation by PPARγ Prevents IL-17–Driven Cancer Growth

Includes: Supplementary data

Journal Articles

5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity

Julie Vincent, Grégoire Mignot, Fanny Chalmin, Sylvain Ladoire, Mélanie Bruchard, Angélique Chevriaux, François Martin, Lionel Apetoh, Cédric Rébé, François Ghiringhelli

Cancer Res (2010) 70 (8): 3052–3061.

https://doi.org/10.1158/0008-5472.CAN-09-3690

Published: 14 April 2010

View article titled, 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity

Includes: Supplementary data

Journal Articles

Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity

Laetitia Aymeric, Lionel Apetoh, François Ghiringhelli, Antoine Tesniere, Isabelle Martins, Guido Kroemer, Mark J. Smyth, Laurence Zitvogel

Cancer Res (2010) 70 (3): 855–858.

https://doi.org/10.1158/0008-5472.CAN-09-3566

Published: 31 January 2010

View article titled, Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity

Journal Articles

Abstract #5664: Activation of the NALP3 inflammasome in dendritic cells induces IL-1\#946;-dependent adaptive immunity against tumors

Antoine Tesniere, Francois Ghiringhelli, Lionel Apetoh, Laurence Zitvogel, Guido Kroemer

Cancer Res (2009) 69 (9_Supplement): 5664.

Published: 01 May 2009

View article titled, Abstract #5664: Activation of the NALP3 inflammasome in dendritic cells induces IL-1\#946;-dependent adaptive immunity against tumors

Journal Articles

Molecular Interactions between Dying Tumor Cells and the Innate Immune System Determine the Efficacy of Conventional Anticancer Therapies

Lionel Apetoh, Antoine Tesniere, François Ghiringhelli, Guido Kroemer, Laurence Zitvogel

Cancer Res (2008) 68 (11): 4026–4030.

https://doi.org/10.1158/0008-5472.CAN-08-0427

Published: 02 June 2008

View article titled, Molecular Interactions between Dying Tumor Cells and the Innate Immune System Determine the Efficacy of Conventional Anticancer Therapies

Journal Articles

Molecular basis of the immunogenicity of cell death during chemotherapy

Laurence Zitvogel, Lionel Apetoh, Francois Ghiringhelli, Antoine Tesniere, Carla Ortiz, Nathalie Chaput, Theo Panaretakis, Jean Kanelopoullos, Guido Kroemer

Cancer Res (2008) 68 (9_Supplement): SY29-04.

Published: 01 May 2008

View article titled, Molecular basis of the immunogenicity of cell death during chemotherapy

Journal Articles

Leveraging the Immune System during Chemotherapy: Moving Calreticulin to the Cell Surface Converts Apoptotic Death from “Silent” to Immunogenic

Michel Obeid, Theocharis Panaretakis, Antoine Tesniere, Nick Joza, Roberta Tufi, Lionel Apetoh, François Ghiringhelli, Laurence Zitvogel, Guido Kroemer

Cancer Res (2007) 67 (17): 7941–7944.

https://doi.org/10.1158/0008-5472.CAN-07-1622

Published: 05 September 2007

View article titled, Leveraging the Immune System during Chemotherapy: Moving Calreticulin to the Cell Surface Converts Apoptotic Death from “Silent” to Immunogenic

Journal Articles

Toll-like receptor 4 -dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Lionel Apetoh, Francois Ghiringhelli, Antoine Tesniere, Fabrice Andre, Suzette Delaloge, Guido Kroemer, Laurence Zitvogel

Cancer Res (2007) 67 (9_Supplement): 3550.

Published: 01 May 2007

View article titled, Toll-like receptor 4 -dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Journal Articles

A novel dendritic cell subset supporting the concept of tumor immunoediting: IFN producing Killer Dendritic cell (IKDC)

Laurence Zitvogel, Julien Taieb, Nathalie Chaput, Cédric Menard, Lionel Apetoh, Evelyn Ullrich, Mathieu Bonmort, Thomas Tursz, Graça Raposo, Hideo Yagita, Bernard Ryffel, Guido Kroemer

Cancer Res (2006) 66 (8_Supplement): 1145.

Published: 15 April 2006

View article titled, A novel dendritic cell subset supporting the concept of tumor immunoediting: IFN producing Killer Dendritic cell (IKDC)

NARROW

Abstract 2358: NR0B2 re-educates myeloid cells within the tumor microenvironment: Potential novel strategy for breast cancer immunotherapy

Abstract P6-05-01: The small heterodimer partner in macrophages reduces expansion of regulatory T cells and enhances immune checkpoint inhibition in breast cancer

Cleaved Caspase-3 Transcriptionally Regulates Angiogenesis-Promoting Chemotherapy Resistance

Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen

Th9 Cells: A Novel CD4 T-cell Subset in the Immune War against Cancer

SOCS3 Transactivation by PPARγ Prevents IL-17–Driven Cancer Growth

5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity

Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity

Abstract #5664: Activation of the NALP3 inflammasome in dendritic cells induces IL-1\#946;-dependent adaptive immunity against tumors

Molecular Interactions between Dying Tumor Cells and the Innate Immune System Determine the Efficacy of Conventional Anticancer Therapies

Molecular basis of the immunogenicity of cell death during chemotherapy

Leveraging the Immune System during Chemotherapy: Moving Calreticulin to the Cell Surface Converts Apoptotic Death from “Silent” to Immunogenic

Toll-like receptor 4 -dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

A novel dendritic cell subset supporting the concept of tumor immunoediting: IFN producing Killer Dendritic cell (IKDC)

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only